Capital Advisory Group Advisory Services, LLC Exact Sciences Corp Transaction History

Capital Advisory Group Advisory Services, LLC

$233 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $18,695 - $40,020	-525 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$57.56 - $82.54 $30,219 - $43,333	525 New	525 $37,000
Q4 2021 Feb 15, 2022	SELL	$72.5 - $100.68 $38,062 - $52,857	-525 Closed	0 $0
Q4 2020 Feb 18, 2021	BUY	$99.61 - $142.12 $52,295 - $74,613	525 New	525 $70,000

Others Institutions Holding EXAS

# of Institutions

609

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

Vanguard Group Inc Valley Forge, PA

18.2M
Shares

$1.22 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

16.5M
Shares

$1.1 Billion
0.12% of portfolio
Wellington Management Group LLP Boston, MA

14.8M
Shares

$989 Million
0.11% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$807 Million
0.01% of portfolio
State Street Corp Boston, MA

8.21M
Shares

$549 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.8B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account